Given the potential importance of RAD51B in processing damaged DNA in haploid leukemia, we asked if RAD51B and the HR pathway were involved in the in vivo response to DNA-damaging chemotherapy in near-haploid B-ALL. This evidence concerns the gene RAD51B and leukemia.